MedTrace Logo

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

NCT04065906 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-08-22

No results posted yet for this study

Summary

To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.

Conditions

  • Neurofeedback
  • Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

BEHAVIORAL

NIRS neurofeedback

Neurofeedback as a treatment for ADHD can be interpreted as a way to increase behavioral inhibition. A method to assess brain activity is functional near-infrared spectroscopy (NIRS), measuring hemodynamic correlates of neural activity.

DRUG

Methylphenidate or Tomoxetine

Methylphenidate is the first line drug of ADHD Tomoxetine is the second line drug of ADHD

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Wenjun Wu, master · Xijing Hospital, The Air Force Medical University

  • Huaning Wang, doctor · Xijing Hospital, The Air Force Medical University

  • Yi Zhang, professor · Xidian University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04065906 on ClinicalTrials.gov